Working… Menu

A Phase 2 Study to Evaluate the Safety and Efficacy of CB-03-01 Solution, a Comparator Solution and Vehicle Solution in Males With Androgenetic Alopecia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02279823
Recruitment Status : Completed
First Posted : October 31, 2014
Last Update Posted : March 13, 2017
Information provided by (Responsible Party):
Intrepid Therapeutics, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 2015
Actual Study Completion Date : May 2016
Certification/Extension First Submitted : March 9, 2017